Literature DB >> 20657029

Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation.

Niels Voigt1, Anne Trausch, Michael Knaut, Klaus Matschke, András Varró, David R Van Wagoner, Stanley Nattel, Ursula Ravens, Dobromir Dobrev.   

Abstract

BACKGROUND: Recent evidence suggests that atrial fibrillation (AF) is maintained by high-frequency reentrant sources with a left-to-right-dominant frequency gradient, particularly in patients with paroxysmal AF (pAF). Unequal left-to-right distribution of inward rectifier K(+) currents has been suggested to underlie this dominant frequency gradient, but this hypothesis has never been tested in humans. METHODS AND
RESULTS: Currents were measured with whole-cell voltage-clamp in cardiomyocytes from right atrial (RA) and left (LA) atrial appendages of patients in sinus rhythm (SR) and patients with AF undergoing cardiac surgery. Western blot was used to quantify protein expression of I(K1) (Kir2.1 and Kir2.3) and I(K,ACh) (Kir3.1 and Kir3.4) subunits. Basal current was ≈2-fold larger in chronic AF (cAF) versus SR patients, without RA-LA differences. In pAF, basal current was ≈2-fold larger in LA versus RA, indicating a left-to-right atrial gradient. In both atria, Kir2.1 expression was ≈2-fold greater in cAF but comparable in pAF versus SR. Kir2.3 levels were unchanged in cAF and RA-pAF but showed a 51% decrease in LA-pAF. In SR, carbachol-activated (2 μmol/L) I(K,ACh) was 70% larger in RA versus LA. This right-to-left atrial gradient was decreased in pAF and cAF caused by reduced I(K,ACh) in RA only. Similarly, in SR, Kir3.1 and Kir3.4 proteins were greater in RA versus LA and decreased in RA of pAF and cAF. Kir3.1 and Kir3.4 expression was unchanged in LA of pAF and cAF.
CONCLUSION: Our results support the hypothesis that a left-to-right gradient in inward rectifier background current contributes to high-frequency sources in LA that maintain pAF. These findings have potentially important implications for development of atrial-selective therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20657029      PMCID: PMC5832445          DOI: 10.1161/CIRCEP.110.954636

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  38 in total

1.  Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart.

Authors:  R Mandapati; A Skanes; J Chen; O Berenfeld; J Jalife
Journal:  Circulation       Date:  2000-01-18       Impact factor: 29.690

2.  Ionic mechanisms of electrical remodeling in human atrial fibrillation.

Authors:  R F Bosch; X Zeng; J B Grammer; K Popovic; C Mewis; V Kühlkamp
Journal:  Cardiovasc Res       Date:  1999-10       Impact factor: 10.787

3.  Suppression of Kir2.3 activity by protein kinase C phosphorylation of the channel protein at threonine 53.

Authors:  G Zhu; Z Qu; N Cui; C Jiang
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

4.  Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation.

Authors:  D R Van Wagoner; A L Pond; P M McCarthy; J S Trimmer; J M Nerbonne
Journal:  Circ Res       Date:  1997-06       Impact factor: 17.367

5.  Effect of vagal stimulation and differential densities of M2 receptor and IK,ACh in canine atria.

Authors:  Qing-Yan Zhao; Cong-Xin Huang; Jin-Jun Liang; Hui Chen; Bo Yang; Hong Jiang; Geng-Shan Li
Journal:  Int J Cardiol       Date:  2007-06-27       Impact factor: 4.164

6.  Left versus right atrial difference in dominant frequency, K(+) channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery.

Authors:  Michael F Swartz; Gregory W Fink; Charles J Lutz; Steven M Taffet; Omer Berenfeld; Karen L Vikstrom; Kimberly Kasprowicz; Luna Bhatta; Ferenc Puskas; Jérôme Kalifa; José Jalife
Journal:  Heart Rhythm       Date:  2009-06-17       Impact factor: 6.343

7.  Paroxysmal atrial fibrillation maintained by nonpulmonary vein sources can be predicted by dominant frequency analysis of atriopulmonary electrograms.

Authors:  Eriko Yokoyama; Toshiyuki Osaka; Yoshio Takemoto; Tomoyuki Suzuki; Atsushi Ito; Kaichiro Kamiya; Itsuo Kodama
Journal:  J Cardiovasc Electrophysiol       Date:  2009-12-15

8.  Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation.

Authors:  Niels Voigt; Adina Friedrich; Manja Bock; Erich Wettwer; Torsten Christ; Michael Knaut; Ruth H Strasser; Ursula Ravens; Dobromir Dobrev
Journal:  Cardiovasc Res       Date:  2007-02-12       Impact factor: 10.787

9.  Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart.

Authors:  A C Skanes; R Mandapati; O Berenfeld; J M Davidenko; J Jalife
Journal:  Circulation       Date:  1998-09-22       Impact factor: 29.690

10.  Frequency-dependent breakdown of wave propagation into fibrillatory conduction across the pectinate muscle network in the isolated sheep right atrium.

Authors:  Omer Berenfeld; Alexey V Zaitsev; Sergey F Mironov; Arkady M Pertsov; José Jalife
Journal:  Circ Res       Date:  2002-06-14       Impact factor: 17.367

View more
  87 in total

Review 1.  Genetic defects in the hotspot of inwardly rectifying K(+) (Kir) channels and their metabolic consequences: a review.

Authors:  Bikash R Pattnaik; Matti P Asuma; Ryan Spott; De-Ann M Pillers
Journal:  Mol Genet Metab       Date:  2011-10-19       Impact factor: 4.797

2.  Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation.

Authors:  Babar Parvez; Joseph Vaglio; Shane Rowan; Raafia Muhammad; Gayle Kucera; Tanya Stubblefield; Shannon Carter; Dan Roden; Dawood Darbar
Journal:  J Am Coll Cardiol       Date:  2012-06-20       Impact factor: 24.094

3.  Nav1.5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels.

Authors:  Marcos Matamoros; Marta Pérez-Hernández; Guadalupe Guerrero-Serna; Irene Amorós; Adriana Barana; Mercedes Núñez; Daniela Ponce-Balbuena; Sandra Sacristán; Ricardo Gómez; Juan Tamargo; Ricardo Caballero; José Jalife; Eva Delpón
Journal:  Cardiovasc Res       Date:  2016-01-19       Impact factor: 10.787

Review 4.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 5.  Report on the Ion Channel Symposium : Organized by the German Cardiac Society Working Group on Cellular Electrophysiology (AG 18).

Authors:  Niels Voigt; Fleur Mason; Dierk Thomas
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-01-08

Review 6.  Atrial remodeling, fibrosis, and atrial fibrillation.

Authors:  José Jalife; Kuljeet Kaur
Journal:  Trends Cardiovasc Med       Date:  2014-12-31       Impact factor: 6.677

Review 7.  Déjà vu in the theories of atrial fibrillation dynamics.

Authors:  José Jalife
Journal:  Cardiovasc Res       Date:  2010-11-19       Impact factor: 10.787

Review 8.  Antiarrhythmic drugs 2013: state of the art.

Authors:  Kapil Kumar; Peter J Zimetbaum
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

9.  Voltage-dependent open-channel block of G protein-gated inward-rectifying K(+) (GIRK) current in rat atrial myocytes by tamoxifen.

Authors:  Svenja Vanheiden; Lutz Pott; Marie-Cécile Kienitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-25       Impact factor: 3.000

10.  Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation.

Authors:  Raphael P Martins; Kuljeet Kaur; Elliot Hwang; Rafael J Ramirez; B Cicero Willis; David Filgueiras-Rama; Steven R Ennis; Yoshio Takemoto; Daniela Ponce-Balbuena; Manuel Zarzoso; Ryan P O'Connell; Hassan Musa; Guadalupe Guerrero-Serna; Uma Mahesh R Avula; Michael F Swartz; Sandesh Bhushal; Makarand Deo; Sandeep V Pandit; Omer Berenfeld; José Jalife
Journal:  Circulation       Date:  2014-01-24       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.